In The News:
Positively Northern Nevada: Friday the 13th a lucky night for fundraisers:
Reno Gazette Journal: Positively Northern Nevada Friday 13th lucky night fundraisers.
Dr. Vincent Lombardi and Annette Whittemore are interviewed by Deborah Waroff and discuss the latest happenings at WPI:
Episode 47 Part 1-Annette Whittemore
Episode 47 Part 2
Episode 48 Part 1- Dr. Vincent Lombardi
Episode 48 Part 2
Appearances on Nevada Newsmakers:
One of WPI's goals is to educate the general public about the institute and the progress the institute is making towards solving critical questions about neuro-immune diseases. One way to keep the public informed about WPI is appearances on Nevada Newsmakers. Nevada Newsmakers provides up to date information on important events within the state of Nevada. This informative show reaches an audience of about 70,000 people per month. The host, Sam Shad, serves of the board of directors for WPI and has a personal interest in neuro-immune diseases because his wife has suffered from fibromyalgia for over twenty years. You can view recent Nevada Newsmakers appearances by clicking on the episode links below.
-Annette Whittemore, WPI President and CEO, Dr. Vincent Lombardi, WPI Research Director, and Marc Johnson, University of Nevada, Reno President, appear on August 26, 2013 episode.
-Annette Whittemore, WPI President and CEO, Dr. Vincent Lombardi, WPI Research Director, and Kris Kruse, Operations Manager at The Nevada Genomics Center, appear on March 6, 2013 episode.
Annette Whittemore, WPI President and CEO, Dr. Vincent Lombardi, WPI Research Director, and Ken Hunter, Professor, Department of Microbiology & Immunology at the University of Nevada, Reno/University of Nevada School of Medicine and WPI’s Scientific Advisory Board Chairman, appear on April 18, 2012 episode.
Dr. Kenny De Meirleir Web Seminars:
These web seminars are part of the project titled Wetenschap voor Patienten, or in English, Science for Patients. This project is a collaboration between Science Alliance and Dutch ME/cvs Vereniging (www.me-cvsvereniging.nl). There are 20 web seminars with Dr. Kenny De Meirleir. Other ME/CFS scientists will follow.
Twelve questions answered about ME, its origin and possible causes.
ME, Co-morbidity and Exclusion Criteria.
Subgroups of Patients.
ME, Th1, Th2 and Th17
Is ME and/or CFS a disease?
Is it possible to diagnose ME/CFS?
Is ME a hereditary condition?
ME and sleep disorders
ME and pain
ME and Hormones
ME, the Immune System and several Viruses.
ME and the Blood Circulation
ME and Gastrointestinal Problems
Chronic Illness associated with mold and mycotoxins: Is naso-sinus fungal biofilm the culprit?
Chronic fatigue syndrome activists launch 'uprising' from their beds
Miami clinic has treated Gulf War illness successfully, but methods have not been disseminated for use in other clinics in the VA system
Antioxidant drug knocks down multiple sclerosis-like disease in mice
Explainer: What is chronic fatigue syndrome?
Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis
Autoimmunity and a wily virus: Is there a link?
Part 1: Sleep: A mystery at the crossroads of neuroscience
Part 2: Sleep: A mystery at the crossroads of neuroscience
Self-reported post-exertional fatigue in Gulf War veterans: Roles of autonomic testing
MS: Slow progression with vitamin D?
Vitamin D3 deficiency results in dysfunctions of immunity with severe fatigue and depression in a variety of diseases
Diseases can stigmatize
Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome
A-not-to-do list for caregivers of the chronically Ill
Illuminating an illness without end: Fellows Friday with Jennifer Brea
ProHealth’s 2013 Advocate of the Year – Jennifer Brea
Translating Science into Clinical Care - March 20-23, 2014 • San Francisco, California: http://www.iacfsme.org/Conferences/2014Conference/2014ProfessionalAgenda/tabid/535/Default.aspx
2014 STANFORD MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME SYMPOSIUM
Advances in Clinical Care and Translational Research
March 19, 2014 • Li Ka Shing Center for Learning and Knowledge, Stanford, California
Bacterial toxin a potential trigger for multiple sclerosis
Does chronic fatigue syndrome need a new name?
The shame of biomedical research in the U.S.
What’s up in 2014? A look ahead for chronic fatigue syndrome
Identifying defining aspects of chronic fatigue syndrome via unsupervised machine learning and feature selection
Opening up data access, not just articles
New rule allows patients to get test results directly from labs, without doctors’ clearance
Poor oxygen uptake may be at the core of the exercise problems in chronic fatigue syndrome
Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis.
Discordant biological and toxicological species responses to TLR3 activation
Tissue hypoxia in autoimmune brain disease, A columbian discovery?
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics
Is Valacyclovir a mood stabilizer?
PLOS ONE: Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis
A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: A focus on potential salivary biomarkers.
A Good-bye to Tom Hennessy – Fierce Advocate: Memorial Tomorrow
Increased Levels of IL-17A Found in Patients with Fibromyalgia
A Tiger Awakes: ME/CFS Research Community Takes A Stand – Blasts Federal Efforts to Create Definition
ME/CFS Clinicians Challenge IOM Contract, Adopt Canadian Consensus Criteria
The Voice of the Patient: A series of reports from the U.S. Food and Drug Administration’s (FDA’s) Patient-Focused Drug Development Initiative
Potential probiotic effects beyond gut: psoriasis, CFS
Increased Brain White Matter Axial Diffusivity Associated with Fatigue, Pain and Hyperalgesia in Gulf War Illness
It is estimated that 25% of Myalgic Encephalomyelitis (ME) patients are severely affected – often housebound and/or bedridden and for many years. They have been largely invisible, greatly misunderstood and mostly ignored.
Sleep Abnormalities in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Review
Discriminative Validity of Metabolic and Workload Measurements to Identify Individuals With Chronic Fatigue Syndrome
Persistent human herpesvirus-6 infection in patients with an inherited form of the virus
The Human Microbiome and Autoimmunity: An Uneasy Coexistence
Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut
Progesterone Protective Effects In Neurodegeneration And Neuroinflammation.
Study Suggests Retroviral Activation/Autoimmunity Possibly Linked in ME/CFS: Dr. Lombardi of WPI Talks to Cort Johnson, March 8, 2013
Important Discovery Exposes Autoimmune Nature of ME/CFS – HERVs Implicated, February 20, 2013
FDA’s Latest Efforts in Patient-focused Drug Development … Now in Full Swing!
Classic microscopy reveals borrelia bacteria
Study Hints of Rituximab MS Benefit
Microbes at home in your gut may also be influencing your brain
The role of gut microbiota in the gut-brain axis: current challenges and perspectives
Abnormal Visual Attention in Myalgic Encephalomyelitis
Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome
February 19, 2013: De Meirleir, et al., Plasmacytoid Dendritic Cells in the Duodenum of Individuals Diagnosed with Myalgic Encephalomyelitis Are Uniquely Immunoreactive to Antibodies to Human Endogenous Retroviral Proteins
January 30, 2013: WPI Welcomes, International ME/CFS Expert - Dr. Kenny De Meirleir
International Medical Press: Andes-virus-induced cytokine storm is partially suppressed by ribavirin